Resources
About Us
Home Report
Store
ELISA Market
ELISA Market Size, Share, Forecast, & Trends Analysis by Type (Direct, Sandwich, Competitive) Offering (Analyzer, Software) Technology (Chemiluminescence, Colorimetry, Fluorescence) Application (Research, Diagnostic) End User - Global Forecast to 2031
Report ID:MRHC - 1041314 Pages: 350 Aug-2024 Formats*: PDF Category: Healthcare Delivery: 24 to 72 HoursThe ELISA Market was valued at $20.49 billion in 2023. This market is expected to reach $32.69 billion by 2031 from an estimated $21.63 billion in 2024, at a CAGR of 6.1% during the forecast period 2024-2031
ELISA Market Size & Forecast
The growth of the ELISA market is primarily driven by the high burden of chronic & infectious diseases, the increasing use of ELISA in clinical applications, advancements in ELISA, and the growing use of ELISA in the food industry. Furthermore, growing research activities in developing countries, increasing R&D for biomarker detection, and the growing focus on vaccine development are expected to offer growth opportunities for market stakeholders.
ELISA Market Growth Drivers
High Burden of Chronic & Infectious Diseases
ELISA is performed to detect or screen patients for diseases such as cancer, HIV, and autoimmune diseases. The rising prevalence of these diseases drives the utilization of ELISA kits. According to the World Health Organization (WHO) report published in July 2023, nearly 39 million people had HIV as of 2022.
ELISA uses antibodies that are specific and sensitive to target antigens. It can detect lower concentrations of biomarkers. In cancer detection, ELISA kits detect biomarkers such as Alpha-fetoprotein (AFP) and β-2microglobulin (B2M). ELISA is easier to perform and provides results faster compared to other tests. According to GLOBOCAN, the number of new cancer cases is expected to rise by 63.4% between 2022 and 2045. Thus, rising cancer incidence and the high preference for ELISA tests in cancer detection and diagnosis drive the growth of this market.
Click here to: Get Free Sample Pages of this Report
Advancements in ELISA
ELISA is used to detect and measure antigens in biological samples. In recent years, key players have been focused on advancing ELISA. The integration of nanomaterials in ELISA is one such advancement that has improved sensitivity, enhanced overall performance, and helped in the detection of trace amounts of proteins or biomarkers. Nanomaterials such as white Fe-based Coordination Polymer Nanozymes (FCPN), Multiwalled Carbon Nanotubes (MWCNTs), and Metallic Nanoparticles (NP) help in hassle-free enzyme loading.
Aptamers produced through chemical synthesis are now replacing antibodies in ELISA procedures. Aptamers can be modified as required and are cheaper to produce. Also, aptamers can be synthesized against a wide range of target molecules; hence, ELISA tests can be used for detecting many chronic & infectious diseases. These advancements have enabled more accurate and faster results, easy processing, and cost and time savings.
ELISA Market Trends
Digital ELISA
Digital ELISA is considered an advanced and sensitive immunoassay technique built on the principles of the traditional ELISA technique. Digital ELISA uses beads to induce enzyme reactions in femtoliter-sized wells that can detect single-enzyme molecules. The technique is used to accurately detect biomarkers or proteins in ultra-low-level concentration solutions. Magnetic microbead detection, single-molecule counting, and electrochemical detection are some of the types of digital ELISA. Digital ELISA helps researchers and scientists optimize results faster and more accurately. Digital ELISA serves applications in environmental monitoring, drug discovery, and clinical diagnostics. For instance, digital ELISA supports neurological research and diagnostics by measuring brain biomarkers. Digital ELISA offers high sensitivity, flexibility, and multiplexed capabilities. Quanterix Corp. (U.S.) offers digital ELISA for the detection of brain biomarkers.
Robotics & Automation
The integration of robotics and automation in ELISA streamlines the entire assay process, from sample preparation to data analysis. Automation helps in precise processing by dispensing accurate amounts of required reagents and samples. It helps in decreasing variabilities from the results and reducing the time required for conducting experiments. Automation and robotics improve accuracy and reproducibility as robots work on algorithms that do not change, reducing the risk of variations in sample volumes and detection time.
Automation and robotics follow system-integrated workflows that result in seamless processing without interruptions. ELISA robots can simultaneously perform pipetting procedures for multiple assays. Simultaneous processing results in reduced manual errors and increases time efficiency. According to Automata (U.K.), the use of ELISA robots reduces manual intervention during assays by 80%-95.25%.
ELISA Market Opportunities
Increasing R&D for Biomarker Detection
Biomarkers are biomolecules present in cells that help in disease detection. Biomarkers are largely used for identifying mutations and other chromosomal abnormalities during the detection of early-stage cancers. Biomarker detection helps in assessing diagnostic, predictive and monitoring results. Patients’ increasing inclination toward personalized medicines is increasing the utilization of ELISA for biomarker detection. In precision medicine, biomarker estimation helps in designing treatment strategies and optimizing therapeutic outcomes for patients. Thus, the growing focus on precision medicine coupled with high cancer prevalence is increasing research in the area of biomarker detection. Also, funding for biomarker R&D is increasing, generating opportunities for market growth. For instance, in August 2023, the National Comprehensive Cancer Network (U.S.), an alliance of 33 cancer centers in the U.S., in partnership with Fight Colorectal Cancer (U.S.), a patient empowerment organization, and Pfizer Inc. (U.S.), announced new grants for initiatives focused on optimizing biomarker-directed therapy for metastatic colorectal cancer.
ELISA Market Analysis: Key Findings
By Type: The Indirect ELISA Segment to Dominate the Market in 2024
Based on type, the ELISA market is segmented into direct ELISA, indirect ELISA, sandwich ELISA, and competitive ELISA. In 2024, the indirect ELISA segment is expected to account for the largest share of 43.5% of the ELISA market. Indirect ELISA is a detection type where a primary antigen-specific antibody is recognized by a secondary conjugated antibody. Indirect ELISA is highly sensitive and flexible, which helps in binding more than one labeled secondary antibody. Indirect ELISA uses fewer labeled antibodies and is used to detect total antibody concentrations in biological samples. Thus, the high sensitivity, flexibility, and cost-effectiveness of indirect ELISA contribute to the segment’s large market share.
By Offering: The Kits & Assays Segment to Dominate the ELISA Market in 2024
Based on offering, the ELISA market is segmented into kits & assays, analyzers, and software. In 2024, the kits & assays segment is expected to account for the largest share of 85.2% of the ELISA market. ELISA kits are commonly used for disease diagnosis, pregnancy testing, cancer detection, vaccine development, and food allergen testing. The rising prevalence of diseases, coupled with growing awareness regarding early disease diagnosis, is contributing to the segment’s large market share.
By Technology: The Colorimetric ELISA Segment to Dominate the Market in 2024
Based on technology, the ELISA market is segmented into chemiluminescence ELISA, colorimetric ELISA, and fluorescence ELISA. In 2024, the colorimetric ELISA segment is expected to account for the largest share of the ELISA market. Colorimetric ELISA uses colored reaction products to produce results. It uses labeled enzymes such as peroxidase or phosphatase for testing. Colorimetric ELISA is used for various types of samples, making it ideal for research applications. Colorimetric ELISA is non-destructive, and the samples can be used for further analysis. These factors support the segment’s large market share.
By Application: The Diagnostic Applications Segment to Dominate the ELISA Market in 2024
Based on application, the ELISA market is segmented into research applications, diagnostic applications, food testing, and other applications. In 2024, the diagnostic applications segment is expected to account for the largest share of the ELISA market. Diagnostic applications are further subsegmented into infectious diseases, autoimmune diseases, oncology, and other diagnostic applications. The increasing prevalence of cancer, autoimmune diseases, and infectious diseases is driving the utilization of ELISA kits in diagnostic applications.
According to the National Institute of Environmental Health Sciences (NIEHS), 50 million people in the U.S. have autoimmune diseases. Thus, the high prevalence of target diseases, coupled with the benefits of ELISA, such as high sensitivity, accuracy, and reliability, supports the segment’s large share.
By End User: The Diagnostic Laboratories Segment to Dominate the ELISA Market in 2024
Based on end user, the ELISA market is segmented into pharmaceutical & biotechnology companies, diagnostic laboratories, CDMOs & CROs, academic & research institutes, food laboratories, and other end users. In 2024, the diagnostic laboratories segment is expected to account for the largest share of the ELISA market. The segment’s large share is attributed to the high prevalence of infectious and chronic diseases, the reliable test results provided by diagnostic laboratories, and the expansion of diagnostic laboratories. Diagnostic laboratories perform various medical tests that help identify and diagnose medical conditions. Diagnostic laboratories are well-equipped with advanced technological solutions and, therefore, are able to process more samples quicker. Thus, the rising burden of diseases and diagnostic laboratories’ high preference for ELISA tests contribute to the segment’s large share.
Geographic Analysis
North America to Dominate the ELISA Market in 2024
In 2024, North America is expected to account for the largest share of 37.7% of the ELISA market. The region’s large share is attributed to pharmaceutical companies’ high focus on R&D, supportive government initiatives, and the presence of large pharmaceutical players in the region. There is also an increased focus on food testing due to the increasing number of food adulteration cases in the region. Key players in North America are also undertaking strategic initiatives to increase food testing capacities in the region. For instance, in June 2024, Spectacular Labs Inc. (U.S.) collaborated with the Canadian Centre for Meat Innovation & Technology to improve food safety testing. Similarly, in June 2023, Bureau Veritas (France) opened its fourth food laboratory in the U.S. in Chesterfield, Missouri. The laboratory offers rapid and conventional microbiology testing for food and agricultural commodities. Such developments are expected to drive the demand for ELISA kits for food testing, supporting the growth of this regional market.
However, Asia-Pacific is slated to register the highest growth rate of 7.1% during the forecast period. The increasing number of healthcare facilities, diagnostic laboratories, and food testing laboratories in Asia-Pacific are driving the demand for ELISA in the region. Additionally, government initiatives for veterinary disease testing are driving the ELISA market in the region. Countries’ growing focus on improving human and animal healthcare, increasing investments in drug discovery, growth in diagnostic testing, and the growing focus on vaccination in Asia-Pacific are driving the demand for ELISA in the region. For instance, in May 2024, the Government of Australia started its vaccination drive for Influenza and released the list of available vaccines (Source: Commonwealth of Australia).
ELISA Market: Key Companies
The report includes a competitive landscape based on an extensive assessment of the product offerings, geographic presence, and key strategic developments of leading market players (2021–2024). The key players operating in the ELISA market include Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), Danaher Corporation (U.S.), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Abbott Laboratories (U.S.), bioMérieux SA (France), Revvity Inc. (U.S.), QuidelOrtho Corporation (U.S.), Becton, Dickinson and Company (U.S.), Repligen Corporation (U.S.), BioLegend (U.S.), and Bio-Techne Corporation (U.S.).
ELISA Market Overview: Latest Developments from Key Industry Players
- In February 2024, Gold Standard Diagnostics. (U.S.) launched Celer AFLA HS, an ELISA test kit for total aflatoxins detection in agricultural products such as maize and corn germ.
- In January 2024, Rockland Immunochemicals, Inc. (U.S.) launched the AccuSignal Nuclease ELISA Kit for the detection of Serratia marcescens endonuclease & turbonuclease used in the manufacturing of biological therapeutics, gene therapies, and vaccines, among others.
- In November 2023, F. Hoffmann-La Roche AG (Switzerland) launched the Elecsys HBeAg quant immunoassay to assess both the presence and quantity of hepatitis B antigen in biological samples.
ELISA Market Research Summary
|
Particulars |
Details |
|
Number of Pages |
350 |
|
Format |
|
|
Forecast Period |
2024-2031 |
|
Base Year |
2023 |
|
CAGR |
6.1% |
|
Estimated Market Size (Value) |
$32.69 Billion by 2031 |
|
Segments Covered |
By Type
By Offering
By Technology
By Application
By End User
|
|
Countries Covered |
North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, Switzerland, Belgium, and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentina, and Rest of Latin America), and the Middle East & Africa (UAE, Saudi Arabia, South Africa, and Rest of Middle East & Africa) |
|
Key Companies Profiled |
Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), Danaher Corporation (U.S.), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Abbott Laboratories (U.S.), bioMérieux SA (France), Revvity Inc. (U.S.), QuidelOrtho Corporation (U.S.), Becton, Dickinson and Company (U.S.), Repligen Corporation (U.S.), BioLegend (U.S.), and Bio-Techne Corporation (U.S.) |
Key questions answered in the ELISA market report:
This report includes qualitative and quantitative analyses of the ELISA market based on type, offering, technology, application, end user, and geography. The report also provides insights on factors impacting market growth, along with a regulatory analysis, a pricing analysis, and Porter’s Five Forces analysis for the ELISA market.
The ELISA market is projected to reach $32.69 billion by 2031 at a CAGR of 6.1% from 2024 to 2031.
Among all the ELISA types studied in this report, in 2024, the indirect ELISA segment is expected to account for the largest share of 43.5% of the ELISA market. The segment’s large share is attributed to the benefits of indirect ELISA such as high sensitivity, specificity, and flexibility, and the ability to capture total antibody concentration from samples.
The growth of this market is driven by various factors, including the increasing burden of target diseases, the growing use of ELISA in clinical applications, the introduction of technologically advanced ELISA analyzers, and the increasing application of ELISA in the food industry. Furthermore, growing research activities in developing countries, growing R&D for biomarker detection, and the increasing focus on vaccine development are expected to offer growth opportunities for market stakeholders.
The key players operating in the ELISA market include Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), Danaher Corporation (U.S.), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Abbott Laboratories (U.S.), bioMérieux SA (France), Revvity Inc. (U.S.), QuidelOrtho Corporation (U.S.), Becton, Dickinson and Company (U.S.), Repligen Corporation (U.S.), BioLegend (U.S.), and Bio-Techne Corporation (U.S.).
Asia-Pacific is slated to register the highest growth rate of 7.1% during the forecast period, primarily due to the increasing number of healthcare facilities, diagnostic laboratories, and food testing laboratories in the region. Additionally, government initiatives supporting veterinary disease testing are supporting market growth in Asia-Pacific.
1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Data Collection & Validation Process
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
2.3. Market Sizing & Forecasting
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.3.3. Market Share Analysis
2.4. Assumptions for the Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Drivers
4.2.1. High Burden of Chronic & Infectious Diseases
4.2.2. Use of ELISA in Clinical Applications
4.2.3. Advancements in ELISA
4.2.4. Use of ELISA in the Food Industry
4.3. Restraints
4.3.1. Possibility of False Positive Results
4.3.2. High Costs of ELISA Antibody Preparation
4.4. Opportunities
4.4.1. Increasing Focus on Vaccine Development
4.4.2. Growing Research Activities in Developing Countries
4.4.3. Increasing R&D for Biomarker Detection
4.5. Challenges
4.5.1. Stringent Regulations for Approval
4.5.2. Use of Alternative Technologies for Disease Diagnosis
4.6. Factor Analysis
4.7. Trends
4.7.1. Digital ELISA
4.7.2. Robotics & Automation
4.7.3. Multiplex ELISA
4.8. Regulatory Analysis
4.9. Pricing Analysis
4.10. Porter’s Five Forces Analysis
5. ELISA Market Assessment—by Type
5.1. Overview
5.2. Direct ELISA
5.3. Indirect ELISA
5.4. Sandwich ELISA
5.5. Competitive ELISA
6. ELISA Market Assessment—by Offering
6.1. Overview
6.2. Kits & Assays
6.3. Analyzers
6.3.1. By Mode
6.3.1.1. Fully Automated
6.3.1.2. Semi-automated
6.3.2. By Type
6.3.2.1. Optical Grating ELISA Analyzers
6.3.2.2. Optical Filter ELISA Analyzers
6.4. Software
7. ELISA Market Assessment—by Technology
7.1. Overview
7.2. Chemiluminescence ELISA
7.3. Colorimetric ELISA
7.4. Fluorescence ELISA
8. ELISA Market Assessment—by Application
8.1. Overview
8.2. Research Applications
8.2.1. Drug Discovery & Monitoring
8.2.1.1. Protein Quantification
8.2.1.2. Antibody Detection
8.2.1.3. Biomarker Discovery
8.2.1.4. Other Drug Discovery & Monitoring Applications
8.2.2. Vaccine Development
8.3. Diagnostic Applications
8.3.1. Infectious Diseases
8.3.2. Autoimmune Diseases
8.3.3. Oncology
8.3.4. Other Diagnostic Applications
8.4. Food Testing
8.5. Other Applications
9. ELISA Market Assessment—by End User
9.1. Overview
9.2. Pharmaceutical & Biotechnology Companies
9.3. Diagnostic Laboratories
9.4. CDMOs & CROs
9.5. Academic & Research Institutes
9.6. Food Laboratories
9.7. Other End Users
10. ELISA Market Assessment—by Geography
10.1. Overview
10.2. North America
10.2.1. U.S.
10.2.2. Canada
10.3. Europe
10.3.1. Germany
10.3.2. France
10.3.3. U.K.
10.3.4. Italy
10.3.5. Spain
10.3.6. Switzerland
10.3.7. Belgium
10.3.8. Rest of Europe (RoE)
10.4. Asia-Pacific
10.4.1. Japan
10.4.2. China
10.4.3. India
10.4.4. South Korea
10.4.5. Australia
10.4.6. Rest of Asia-Pacific (RoAPAC)
10.5. Latin America
10.5.1. Brazil
10.5.2. Mexico
10.5.3. Rest of Latin America (RoLATAM)
10.6. Middle East & Africa
11. Competition Analysis
11.1. Overview
11.2. Key Growth Strategies of Leading Players
11.3. Competitive Benchmarking
11.4. Competitive Dashboard
11.4.1. Industry Leaders
11.4.2. Market Differentiators
11.4.3. Vanguards
11.4.4. Emerging Companies
11.5. Market Share Analysis/Market Rankings of Key Players (2023)
12. Company Profiles (Company Overview, Financial Overview, Product Portfolio, Strategic Developments, and SWOT Analysis)
12.1. Thermo Fisher Scientific Inc.
12.2. Merck KGaA
12.3. Bio-Rad Laboratories, Inc.
12.4. F. Hoffmann-La Roche AG
12.5. Danaher Corporation
12.6. QIAGEN N.V.
12.7. Agilent Technologies, Inc.
12.8. Abbott Laboratories
12.9. bioMérieux SA
12.10. Revvity, Inc.
12.11. QuidelOrtho Corporation
12.12. Becton, Dickinson and Company
12.13. Repligen Corporation
12.14. BioLegend
12.15. Bio-Techne Corporation
(Note: SWOT analysis will be provided for the top 5 companies.)
13. Appendix
13.1. Available Customization
13.2. Related Reports
List of Tables
Table 1 Global ELISA Market, by Type, 2022–2031 (USD Million)
Table 2 Global Direct ELISA Market, by Country/Region, 2022–2031 (USD Million)
Table 3 Global Indirect ELISA Market, by Country/Region, 2022–2031 (USD Million)
Table 4 Global Sandwich ELISA Market, by Country/Region, 2022–2031 (USD Million)
Table 5 Global Competitive ELISA Market, by Country/Region, 2022–2031 (USD Million)
Table 6 Global ELISA Market, by Offering, 2022–2031 (USD Million)
Table 7 Global ELISA Kits & Assays Market, by Country/Region, 2022–2031 (USD Million)
Table 8 Global ELISA Analyzers Market, by Mode, 2022–2031 (USD Million)
Table 9 Global ELISA Analyzers Market, by Country/Region, 2022–2031 (USD Million)
Table 10 Global Fully Automated ELISA Analyzers Market, by Country/Region, 2022–2031 (USD Million)
Table 11 Global Semi-automated ELISA Analyzers Market, by Country/Region, 2022–2031 (USD Million)
Table 12 Global ELISA Analyzers Market, by Type, 2022–2031 (USD Million)
Table 13 Global Optical Grating ELISA Analyzers Market, by Country/Region, 2022–2031 (USD Million)
Table 14 Global Optical Filter ELISA Analyzers Market, by Country/Region, 2022–2031 (USD Million)
Table 15 Global ELISA Software Market, by Country/Region, 2022–2031 (USD Million)
Table 16 Global ELISA Market, by Technology, 2022–2031 (USD Million)
Table 17 Global Chemiluminescence-based ELISA Market, by Country/Region, 2022–2031 (USD Million)
Table 18 Global Colorimetric-based ELISA Market, by Country/Region, 2022–2031 (USD Million)
Table 19 Global Fluorescence-based ELISA Market, by Country/Region, 2022–2031 (USD Million)
Table 20 Global ELISA Market, by Application, 2022–2031 (USD Million)
Table 21 Global ELISA Market for Research Applications, by Type, 2022–2031 (USD Million)
Table 22 Global ELISA Market for Research Applications, by Country/Region, 2022–2031 (USD Million)
Table 23 Global ELISA Market for Drug Discovery & Monitoring, by Type, 2022–2031 (USD Million)
Table 24 Global ELISA Market for Drug Discovery & Monitoring, by Country/Region, 2022–2031 (USD Million)
Table 25 Global ELISA Market for Protein Quantification, by Country/Region, 2022–2031 (USD Million)
Table 26 Global ELISA Market for Antibody Detection, by Country/Region, 2022–2031 (USD Million)
Table 27 Global ELISA Market for Biomarker Discovery, by Country/Region, 2022–2031 (USD Million)
Table 28 Global ELISA Market for Other Drug Discovery & Monitoring Applications, by Country/Region, 2022–2031 (USD Million)
Table 29 Global ELISA Market for Vaccine Development, by Country/Region, 2022–2031 (USD Million)
Table 30 Global ELISA Market for Diagnostic Applications, by Type, 2022–2031 (USD Million)
Table 31 Global ELISA Market for Diagnostic Applications, by Country/Region, 2022–2031 (USD Million)
Table 32 Global ELISA Market for Infectious Diseases, by Country/Region, 2022–2031 (USD Million)
Table 33 Global ELISA Market for Autoimmune Diseases, by Country/Region, 2022–2031 (USD Million)
Table 34 Global ELISA Market for Oncology, by Country/Region, 2022–2031 (USD Million)
Table 35 Global ELISA Market for Other Diagnostic Applications, by Country/Region, 2022–2031 (USD Million)
Table 36 Global ELISA Market for Food Testing, by Country/Region, 2022–2031 (USD Million)
Table 37 Global ELISA Market for Other Applications, by Country/Region, 2022–2031 (USD Million)
Table 38 Global ELISA Market, by End User, 2022–2031 (USD Million)
Table 39 Global ELISA Market for Pharmaceutical & Biotechnology Companies, by Country/Region, 2022–2031 (USD Million)
Table 40 Global ELISA Market for Diagnostic Laboratories, by Country/Region, 2022–2031 (USD Million)
Table 41 Global ELISA Market for CDMOs & CROs, by Country/Region, 2022–2031 (USD Million)
Table 42 Global ELISA Market for Academic & Research Institutes, by Country/Region, 2022–2031 (USD Million)
Table 43 Global ELISA Market for Food Laboratories, by Country/Region, 2022–2031 (USD Million)
Table 44 Global ELISA Market for Other End Users, by Country/Region, 2022–2031 (USD Million)
Table 45 Global ELISA Market by Country/Region, 2022–2031 (USD Million)
Table 46 North America: ELISA Market, by Country, 2022-2031 (USD Million)
Table 47 North America: ELISA Market, by Type, 2022-2031 (USD Million)
Table 48 North America: ELISA Market, by Offering, 2022-2031 (USD Million)
Table 49 North America: ELISA Analyzers Market by Mode, 2022–2031 (USD Million)
Table 50 North America: ELISA Analyzers Market by Type, 2022–2031 (USD Million)
Table 51 North America: ELISA Market by Technology, 2022-2031 (USD Million)
Table 52 North America: ELISA Market by Application, 2022-2031 (USD Million)
Table 53 North America: ELISA Market for Research Applications, by Type, 2022–2031 (USD Million)
Table 54 North America: ELISA Market for Drug Discovery & Monitoring, by Type, 2022–2031 (USD Million)
Table 55 North America: ELISA Market for Diagnostic Applications, by Type, 2022–2031 (USD Million)
Table 56 North America: ELISA Market, by End User, 2022-2031 (USD Million)
Table 57 U.S.: ELISA Market, by Type, 2022-2031 (USD Million)
Table 58 U.S.: ELISA Market, by Offering, 2022-2031 (USD Million)
Table 59 U.S.: ELISA Analyzers Market, by Mode, 2022–2031 (USD Million)
Table 60 U.S.: ELISA Analyzers Market, by Type, 2022–2031 (USD Million)
Table 61 U.S.: ELISA Market, by Technology, 2022-2031 (USD Million)
Table 62 U.S.: ELISA Market, by Application, 2022-2031 (USD Million)
Table 63 U.S.: ELISA Market for Research Applications, by Type, 2022–2031 (USD Million)
Table 64 U.S.: ELISA Market for Drug Discovery & Monitoring, by Type, 2022–2031 (USD Million)
Table 65 U.S.: ELISA Market for Diagnostic Applications, by Type, 2022–2031 (USD Million)
Table 66 U.S.: ELISA Market, by End User, 2022-2031 (USD Million)
Table 67 Canada: ELISA Market, by Type, 2022-2031 (USD Million)
Table 68 Canada: ELISA Market, by Offering, 2022-2031 (USD Million)
Table 69 Canada: ELISA Analyzers Market, by Mode, 2022–2031 (USD Million)
Table 70 Canada: ELISA Analyzers Market, by Type, 2022–2031 (USD Million)
Table 71 Canada: ELISA Market, by Technology, 2022-2031 (USD Million)
Table 72 Canada: ELISA Market, by Application, 2022-2031 (USD Million)
Table 73 Canada: ELISA Market for Research Applications, by Type, 2022–2031 (USD Million)
Table 74 Canada: ELISA Market for Drug Discovery & Monitoring, by Type, 2022–2031 (USD Million)
Table 75 Canada: ELISA Market for Diagnostic Applications, by Type, 2022–2031 (USD Million)
Table 76 Canada: ELISA Market, by End User, 2022-2031 (USD Million)
Table 77 Europe: ELISA Market, by Country/Region, 2022-2031 (USD Million)
Table 78 Europe: ELISA Market, by Type, 2022-2031 (USD Million)
Table 79 Europe: ELISA Market, by Offering, 2022-2031 (USD Million)
Table 80 Europe: ELISA Analyzers Market, by Mode, 2022–2031 (USD Million)
Table 81 Europe: ELISA Analyzers Market, by Type, 2022–2031 (USD Million)
Table 82 Europe: ELISA Market, by Technology, 2022-2031 (USD Million)
Table 83 Europe: ELISA Market, by Application, 2022-2031 (USD Million)
Table 84 Europe: ELISA Market for Research Applications, by Type, 2022–2031 (USD Million)
Table 85 Europe: ELISA Market for Drug Discovery & Monitoring, by Type, 2022–2031 (USD Million)
Table 86 Europe: ELISA Market for Diagnostic Applications, by Type, 2022–2031 (USD Million)
Table 87 Europe: ELISA Market, by End User, 2022-2031 (USD Million)
Table 88 Germany: ELISA Market, by Type, 2022-2031 (USD Million)
Table 89 Germany: ELISA Market, by Offering, 2022-2031 (USD Million)
Table 90 Germany: ELISA Analyzers Market, by Mode, 2022–2031 (USD Million)
Table 91 Germany: ELISA Analyzers Market, by Type, 2022–2031 (USD Million)
Table 92 Germany: ELISA Market, by Technology, 2022-2031 (USD Million)
Table 93 Germany: ELISA Market, by Application, 2022-2031 (USD Million)
Table 94 Germany: ELISA Market for Research Applications, by Type, 2022–2031 (USD Million)
Table 95 Germany: ELISA Market for Drug Discovery & Monitoring, by Type, 2022–2031 (USD Million)
Table 96 Germany: ELISA Market for Diagnostic Applications, by Type, 2022–2031 (USD Million)
Table 97 Germany: ELISA Market, by End User, 2022-2031 (USD Million)
Table 98 France: ELISA Market, by Type, 2022-2031 (USD Million)
Table 99 France: ELISA Market, by Offering, 2022-2031 (USD Million)
Table 100 France: ELISA Analyzers Market, by Mode, 2022–2031 (USD Million)
Table 101 France: ELISA Analyzers Market, by Type, 2022–2031 (USD Million)
Table 102 France: ELISA Market, by Technology, 2022-2031 (USD Million)
Table 103 France: ELISA Market, by Application, 2022-2031 (USD Million)
Table 104 France: ELISA Market for Research Applications, by Type, 2022–2031 (USD Million)
Table 105 France: ELISA Market for Drug Discovery & Monitoring, by Type, 2022–2031 (USD Million)
Table 106 France: ELISA Market for Diagnostic Applications, by Type, 2022–2031 (USD Million)
Table 107 France: ELISA Market, by End User, 2022-2031 (USD Million)
Table 108 U.K.: ELISA Market, by Type, 2022-2031 (USD Million)
Table 109 U.K.: ELISA Market, by Offering, 2022-2031 (USD Million)
Table 110 U.K.: ELISA Analyzers Market, by Mode, 2022–2031 (USD Million)
Table 111 U.K.: ELISA Analyzers Market, by Type, 2022–2031 (USD Million)
Table 112 U.K.: ELISA Market, by Technology, 2022-2031 (USD Million)
Table 113 U.K.: ELISA Market, by Application, 2022-2031 (USD Million)
Table 114 U.K.: ELISA Market for Research Applications, by Type, 2022–2031 (USD Million)
Table 115 U.K.: ELISA Market for Drug Discovery & Monitoring, by Type, 2022–2031 (USD Million)
Table 116 U.K.: ELISA Market for Diagnostic Applications, by Type, 2022–2031 (USD Million)
Table 117 U.K.: ELISA Market, by End User, 2022-2031 (USD Million)
Table 118 Italy: ELISA Market, by Type, 2022-2031 (USD Million)
Table 119 Italy: ELISA Market, by Offering, 2022-2031 (USD Million)
Table 120 Italy: ELISA Analyzers Market, by Mode, 2022–2031 (USD Million)
Table 121 Italy: ELISA Analyzers Market, by Type, 2022–2031 (USD Million)
Table 122 Italy: ELISA Market, by Technology, 2022-2031 (USD Million)
Table 123 Italy: ELISA Market, by Application, 2022-2031 (USD Million)
Table 124 Italy: ELISA Market for Research Applications, by Type, 2022–2031 (USD Million)
Table 125 Italy: ELISA Market for Drug Discovery & Monitoring, by Type, 2022–2031 (USD Million)
Table 126 Italy: ELISA Market for Diagnostic Applications, by Type, 2022–2031 (USD Million)
Table 127 Italy: ELISA Market, by End User, 2022-2031 (USD Million)
Table 128 Spain: ELISA Market, by Type, 2022-2031 (USD Million)
Table 129 Spain: ELISA Market, by Offering, 2022-2031 (USD Million)
Table 130 Spain: ELISA Analyzers Market, by Mode, 2022–2031 (USD Million)
Table 131 Spain: ELISA Analyzers Market, by Type, 2022–2031 (USD Million)
Table 132 Spain: ELISA Market, by Technology, 2022-2031 (USD Million)
Table 133 Spain: ELISA Market, by Application, 2022-2031 (USD Million)
Table 134 Spain: ELISA Market for Research Applications, by Type, 2022–2031 (USD Million)
Table 135 Spain: ELISA Market for Drug Discovery & Monitoring, by Type, 2022–2031 (USD Million)
Table 136 Spain: ELISA Market for Diagnostic Applications, by Type, 2022–2031 (USD Million)
Table 137 Spain: ELISA Market, by End User, 2022-2031 (USD Million)
Table 138 Switzerland: ELISA Market, by Type, 2022-2031 (USD Million)
Table 139 Switzerland: ELISA Market, by Offering, 2022-2031 (USD Million)
Table 140 Switzerland: ELISA Analyzers Market, by Mode, 2022–2031 (USD Million)
Table 141 Switzerland: ELISA Analyzers Market, by Type, 2022–2031 (USD Million)
Table 142 Switzerland: ELISA Market, by Technology, 2022-2031 (USD Million)
Table 143 Switzerland: ELISA Market, by Application, 2022-2031 (USD Million)
Table 144 Switzerland: ELISA Market for Research Applications, by Type, 2022–2031 (USD Million)
Table 145 Switzerland: ELISA Market for Drug Discovery & Monitoring, by Type, 2022–2031 (USD Million)
Table 146 Switzerland: ELISA Market for Diagnostic Applications, by Type, 2022–2031 (USD Million)
Table 147 Switzerland: ELISA Market, by End User, 2022-2031 (USD Million)
Table 148 Belgium: ELISA Market, by Type, 2022-2031 (USD Million)
Table 149 Belgium: ELISA Market, by Offering, 2022-2031 (USD Million)
Table 150 Belgium: ELISA Analyzers Market, by Mode, 2022–2031 (USD Million)
Table 151 Belgium: ELISA Analyzers Market, by Type, 2022–2031 (USD Million)
Table 152 Belgium: ELISA Market, by Technology, 2022-2031 (USD Million)
Table 153 Belgium: ELISA Market, by Application, 2022-2031 (USD Million)
Table 154 Belgium: ELISA Market for Research Applications, by Type, 2022–2031 (USD Million)
Table 155 Belgium: ELISA Market for Drug Discovery & Monitoring, by Type, 2022–2031 (USD Million)
Table 156 Belgium: ELISA Market for Diagnostic Applications, by Type, 2022–2031 (USD Million)
Table 157 Belgium: ELISA Market, by End User, 2022-2031 (USD Million)
Table 158 Rest of Europe: ELISA Market, by Type, 2022-2031 (USD Million)
Table 159 Rest of Europe: ELISA Market, by Offering, 2022-2031 (USD Million)
Table 160 Rest of Europe: ELISA Analyzers Market, by Mode, 2022–2031 (USD Million)
Table 161 Rest of Europe: ELISA Analyzers Market, by Type, 2022–2031 (USD Million)
Table 162 Rest of Europe: ELISA Market, by Technology, 2022-2031 (USD Million)
Table 163 Rest of Europe: ELISA Market, by Application, 2022-2031 (USD Million)
Table 164 Rest of Europe: ELISA Market for Research Applications, by Type, 2022–2031 (USD Million)
Table 165 Rest of Europe: ELISA Market for Drug Discovery & Monitoring, by Type, 2022–2031 (USD Million)
Table 166 Rest of Europe: ELISA Market for Diagnostic Applications, by Type, 2022–2031 (USD Million)
Table 167 Rest of Europe: ELISA Market, by End User, 2022-2031 (USD Million)
Table 168 Asia-Pacific: ELISA Market, by Country/Region, 2022-2031 (USD Million)
Table 169 Asia-Pacific: ELISA Market, by Type, 2022-2031 (USD Million)
Table 170 Asia-Pacific: ELISA Market, by Offering, 2022-2031 (USD Million)
Table 171 Asia-Pacific: ELISA Analyzers Market, by Mode, 2022–2031 (USD Million)
Table 172 Asia-Pacific: ELISA Analyzers Market, by Type, 2022–2031 (USD Million)
Table 173 Asia-Pacific: ELISA Market, by Technology, 2022-2031 (USD Million)
Table 174 Asia-Pacific: ELISA Market, by Application, 2022-2031 (USD Million)
Table 175 Asia-Pacific: ELISA Market for Research Applications, by Type, 2022–2031 (USD Million)
Table 176 Asia-Pacific: ELISA Market for Drug Discovery & Monitoring, by Type, 2022–2031 (USD Million)
Table 177 Asia-Pacific: ELISA Market for Diagnostic Applications, by Type, 2022–2031 (USD Million)
Table 178 Asia-Pacific: ELISA Market, by End User, 2022-2031 (USD Million)
Table 179 China: ELISA Market, by Type, 2022-2031 (USD Million)
Table 180 China: ELISA Market, by Offering, 2022-2031 (USD Million)
Table 181 China: ELISA Analyzers Market, by Mode, 2022–2031 (USD Million)
Table 182 China: ELISA Analyzers Market, by Type, 2022–2031 (USD Million)
Table 183 China: ELISA Market, by Technology, 2022-2031 (USD Million)
Table 184 China: ELISA Market, by Application, 2022-2031 (USD Million)
Table 185 China: ELISA Market for Research Applications, by Type, 2022–2031 (USD Million)
Table 186 China: ELISA Market for Drug Discovery & Monitoring, by Type, 2022–2031 (USD Million)
Table 187 China: ELISA Market for Diagnostic Applications, by Type, 2022–2031 (USD Million)
Table 188 China: ELISA Market, by End User, 2022-2031 (USD Million)
Table 189 Japan: ELISA Market, by Type, 2022-2031 (USD Million)
Table 190 Japan: ELISA Market, by Offering, 2022-2031 (USD Million)
Table 191 Japan: ELISA Analyzers Market, by Mode, 2022–2031 (USD Million)
Table 192 Japan: ELISA Analyzers Market, by Type, 2022–2031 (USD Million)
Table 193 Japan: ELISA Market, by Technology, 2022-2031 (USD Million)
Table 194 Japan: ELISA Market, by Application, 2022-2031 (USD Million)
Table 195 Japan: ELISA Market for Research Applications, by Type, 2022–2031 (USD Million)
Table 196 Japan: ELISA Market for Drug Discovery & Monitoring, by Type, 2022–2031 (USD Million)
Table 197 Japan: ELISA Market for Diagnostic Applications, by Type, 2022–2031 (USD Million)
Table 198 Japan: ELISA Market, by End User, 2022-2031 (USD Million)
Table 199 India: ELISA Market, by Type, 2022-2031 (USD Million)
Table 200 India: ELISA Market, by Offering, 2022-2031 (USD Million)
Table 201 India: ELISA Analyzers Market, by Mode, 2022–2031 (USD Million)
Table 202 India: ELISA Analyzers Market, by Type, 2022–2031 (USD Million)
Table 203 India: ELISA Market, by Technology, 2022-2031 (USD Million)
Table 204 India: ELISA Market, by Application, 2022-2031 (USD Million)
Table 205 India: ELISA Market for Research Applications, by Type, 2022–2031 (USD Million)
Table 206 India: ELISA Market for Drug Discovery & Monitoring, by Type, 2022–2031 (USD Million)
Table 207 India: ELISA Market for Diagnostic Applications, by Type, 2022–2031 (USD Million)
Table 208 India: ELISA Market, by End User, 2022-2031 (USD Million)
Table 209 South Korea: ELISA Market, by Type, 2022-2031 (USD Million)
Table 210 South Korea: ELISA Market, by Offering, 2022-2031 (USD Million)
Table 211 South Korea: ELISA Analyzers Market, by Mode, 2022–2031 (USD Million)
Table 212 South Korea: ELISA Analyzers Market, by Type, 2022–2031 (USD Million)
Table 213 South Korea: ELISA Market, by Technology, 2022-2031 (USD Million)
Table 214 South Korea: ELISA Market, by Application, 2022-2031 (USD Million)
Table 215 South Korea: ELISA Market for Research Applications, by Type, 2022–2031 (USD Million)
Table 216 South Korea: ELISA Market for Drug Discovery & Monitoring, by Type, 2022–2031 (USD Million)
Table 217 South Korea: ELISA Market for Diagnostic Applications, by Type, 2022–2031 (USD Million)
Table 218 South Korea: ELISA Market, by End User, 2022-2031 (USD Million)
Table 219 Australia: ELISA Market, by Type, 2022-2031 (USD Million)
Table 220 Australia: ELISA Market, by Offering, 2022-2031 (USD Million)
Table 221 Australia: ELISA Analyzers Market, by Mode, 2022–2031 (USD Million)
Table 222 Australia: ELISA Analyzers Market, by Type, 2022–2031 (USD Million)
Table 223 Australia: ELISA Market, by Technology, 2022-2031 (USD Million)
Table 224 Australia: ELISA Market, by Application, 2022-2031 (USD Million)
Table 225 Australia: ELISA Market for Research Applications, by Type, 2022–2031 (USD Million)
Table 226 Australia: ELISA Market for Drug Discovery & Monitoring, by Type, 2022–2031 (USD Million)
Table 227 Australia: ELISA Market for Diagnostic Applications, by Type, 2022–2031 (USD Million)
Table 228 Australia: ELISA Market, by End User, 2022-2031 (USD Million)
Table 229 Rest of Asia-Pacific: ELISA Market, by Type, 2022-2031 (USD Million)
Table 230 Rest of Asia-Pacific: ELISA Market, by Offering, 2022-2031 (USD Million)
Table 231 Rest of Asia-Pacific: ELISA Analyzers Market, by Mode, 2022–2031 (USD Million)
Table 232 Rest of Asia-Pacific: ELISA Analyzers Market, by Type, 2022–2031 (USD Million)
Table 233 Rest of Asia-Pacific: ELISA Market, by Technology, 2022-2031 (USD Million)
Table 234 Rest of Asia-Pacific: ELISA Market, by Application, 2022-2031 (USD Million)
Table 235 Rest of Asia-Pacific: ELISA Market for Research Applications, by Type, 2022–2031 (USD Million)
Table 236 Rest of Asia-Pacific: ELISA Market for Drug Discovery & Monitoring, by Type, 2022–2031 (USD Million)
Table 237 Rest of Asia-Pacific: ELISA Market for Diagnostic Applications, by Type, 2022–2031 (USD Million)
Table 238 Rest of Asia-Pacific: ELISA Market, by End User, 2022-2031 (USD Million)
Table 239 Latin America: ELISA Market, by Country/Region, 2022-2031 (USD Million)
Table 240 Latin America: ELISA Market, by Type, 2022-2031 (USD Million)
Table 241 Latin America: ELISA Market, by Offering, 2022-2031 (USD Million)
Table 242 Latin America: ELISA Analyzers Market, by Mode, 2022–2031 (USD Million)
Table 243 Latin America: ELISA Analyzers Market, by Type, 2022–2031 (USD Million)
Table 244 Latin America: ELISA Market, by Technology, 2022-2031 (USD Million)
Table 245 Latin America: ELISA Market, by Application, 2022-2031 (USD Million)
Table 246 Latin America: ELISA Market for Research Applications, by Type, 2022–2031 (USD Million)
Table 247 Latin America: ELISA Market for Drug Discovery & Monitoring, by Type, 2022–2031 (USD Million)
Table 248 Latin America: ELISA Market for Diagnostic Applications, by Type, 2022–2031 (USD Million)
Table 249 Latin America: ELISA Market, by End User, 2022-2031 (USD Million)
Table 250 Brazil: ELISA Market, by Type, 2022-2031 (USD Million)
Table 251 Brazil: ELISA Market, by Offering, 2022-2031 (USD Million)
Table 252 Brazil: ELISA Analyzers Market, by Mode, 2022–2031 (USD Million)
Table 253 Brazil: ELISA Analyzers Market, by Type, 2022–2031 (USD Million)
Table 254 Brazil: ELISA Market, by Technology, 2022-2031 (USD Million)
Table 255 Brazil: ELISA Market, by Application, 2022-2031 (USD Million)
Table 256 Brazil: ELISA Market for Research Applications, by Type, 2022–2031 (USD Million)
Table 257 Brazil: ELISA Market for Drug Discovery & Monitoring, by Type, 2022–2031 (USD Million)
Table 258 Brazil: ELISA Market for Diagnostic Applications, by Type, 2022–2031 (USD Million)
Table 259 Brazil: ELISA Market, by End User, 2022-2031 (USD Million)
Table 260 Mexico: ELISA Market, by Type, 2022-2031 (USD Million)
Table 261 Mexico: ELISA Market, by Offering, 2022-2031 (USD Million)
Table 262 Mexico: ELISA Analyzers Market, by Mode, 2022–2031 (USD Million)
Table 263 Mexico: ELISA Analyzers Market, by Type, 2022–2031 (USD Million)
Table 264 Mexico: ELISA Market, by Technology, 2022-2031 (USD Million)
Table 265 Mexico: ELISA Market, by Application, 2022-2031 (USD Million)
Table 266 Mexico: ELISA Market for Research Applications, by Type, 2022–2031 (USD Million)
Table 267 Mexico: ELISA Market for Drug Discovery & Monitoring, by Type, 2022–2031 (USD Million)
Table 268 Mexico: ELISA Market for Diagnostic Applications, by Type, 2022–2031 (USD Million)
Table 269 Mexico: ELISA Market, by End User, 2022-2031 (USD Million)
Table 270 Rest of Latin America: ELISA Market, by Type, 2022-2031 (USD Million)
Table 271 Rest of Latin America: ELISA Market, by Offering, 2022-2031 (USD Million)
Table 272 Rest of Latin America: ELISA Analyzers Market, by Mode, 2022–2031 (USD Million)
Table 273 Rest of Latin America: ELISA Analyzers Market, by Type, 2022–2031 (USD Million)
Table 274 Rest of Latin America: ELISA Market, by Technology, 2022-2031 (USD Million)
Table 275 Rest of Latin America: ELISA Market, by Application, 2022-2031 (USD Million)
Table 276 Rest of Latin America: ELISA Market for Research Applications, by Type, 2022–2031 (USD Million)
Table 277 Rest of Latin America: ELISA Market for Drug Discovery & Monitoring, by Type, 2022–2031 (USD Million)
Table 278 Rest of Latin America: ELISA Market for Diagnostic Applications, by Type, 2022–2031 (USD Million)
Table 279 Rest of Latin America: ELISA Market, by End User, 2022-2031 (USD Million)
Table 280 Middle East & Africa: ELISA Market, by Type, 2022-2031 (USD Million)
Table 281 Middle East & Africa: ELISA Market, by Offering, 2022-2031 (USD Million)
Table 282 Middle East & Africa: ELISA Analyzers Market, by Mode, 2022–2031 (USD Million)
Table 283 Middle East & Africa: ELISA Analyzers Market, by Type, 2022–2031 (USD Million)
Table 284 Middle East & Africa: ELISA Market, by Technology, 2022-2031 (USD Million)
Table 285 Middle East & Africa: ELISA Market, by Application, 2022-2031 (USD Million)
Table 286 Middle East & Africa: ELISA Market for Research Applications, by Type, 2022–2031 (USD Million)
Table 287 Middle East & Africa: ELISA Market for Drug Discovery & Monitoring, by Type, 2022–2031 (USD Million)
Table 288 Middle East & Africa: ELISA Market for Diagnostic Applications, by Type, 2022–2031 (USD Million)
Table 289 Middle East & Africa: ELISA Market, by End User, 2022-2031 (USD Million)
Table 290 Recent Developments, by Company, 2021–2024
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6 Market Size Estimation
Figure 7 Global ELISA Market, by Type, 2024 Vs. 2031 (USD Million)
Figure 8 Global ELISA Market, by Offering, 2024 Vs. 2031 (USD Million)
Figure 9 Global ELISA Market, by Technology, 2024 Vs. 2031 (USD Million)
Figure 10 Global ELISA Market, by Application, 2024 Vs. 2031 (USD Million)
Figure 11 Global ELISA Market, by End User, 2024 Vs. 2031 (USD Million)
Figure 12 Global ELISA Market, by Geography
Figure 13 Impact Analysis of Market Dynamics
Figure 14 Global ELISA Market, by Type, 2024 Vs. 2031 (USD Million)
Figure 15 Global ELISA Market, by Offering, 2024 Vs. 2031 (USD Million)
Figure 16 Global ELISA Market, by Technology, 2024 Vs. 2031 (USD Million)
Figure 17 Global ELISA Market, by Application, 2024 Vs. 2031 (USD Million)
Figure 18 Global ELISA Market, by End User, 2024 Vs. 2031 (USD Million)
Figure 19 Global ELISA Market, by Geography, 2024 Vs. 2031 (USD Million)
Figure 20 North America: ELISA Market Snapshot
Figure 21 Europe: ELISA Market Snapshot
Figure 22 Asia-Pacific: ELISA Market Snapshot
Figure 23 Latin America: ELISA Market Snapshot
Figure 24 Key Growth Strategies Adopted by Leading Players, 2021–2024
Figure 25 Global ELISA Market: Competitive Benchmarking, by Offering
Figure 26 Global ELISA Market: Competitive Benchmarking, by Geography
Figure 27 Global ELISA Market: Competitive Dashboard
Figure 28 Global ELISA Market: Market Share Analysis/Market Rankings of Key Players (2023)
Figure 29 Thermo Fisher Scientific Inc.: Financial Snapshot (2023)
Figure 30 Merck KGaA: Financial Snapshot (2023)
Figure 31 Bio-Rad Laboratories, Inc.: Financial Snapshot (2023)
Figure 32 F. Hoffmann-La Roche AG: Financial Snapshot (2023)
Figure 33 Danaher Corporation: Financial Snapshot (2023)
Figure 34 QIAGEN N.V.: Financial Snapshot (2023)
Figure 35 Agilent Technologies, Inc.: Financial Snapshot (2023)
Figure 36 Abbott Laboratories: Financial Snapshot (2023)
Figure 37 bioMérieux SA: Financial Snapshot (2023)
Figure 38 Revvity, Inc.: Financial Snapshot (2023)
Figure 39 QuidelOrtho Corporation: Financial Snapshot (2023)
Figure 40 Becton, Dickinson and Company: Financial Snapshot (2023)
Figure 41 Repligen Corporation: Financial Snapshot (2023)
Figure 42 Bio-Techne Corporation: Financial Snapshot (2023)
Author Name:
Proudly Partnering With Enterprises Around the Globe
Quick Contact
Related Reports
Veterinary Immunodiagnostics Market - Global Opportunity Analysis and Industry Forecast (2022-2029)
Published Date: Jun-2022
Lab Automation Market - Global Opportunity Analysis and Industry Forecast (2024-2031)
Published Date: Jan-2024
Latin America Livestock Diagnostics Market - Opportunity Analysis and Industry Forecast (2024-2030)
Published Date: Jul-2024
Asia-Pacific Livestock Diagnostics Market - Opportunity Analysis and Industry Forecast (2024-2030)
Published Date: Jul-2024
